ImageneBio (IMA) EPS (Basic) Growth (3y) (2023 - 2025)
ImageneBio (IMA) EPS (Basic) Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | -38.31% |
| 10 | ImageneBio | 49.67 Mn | -85.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 79.48% |
| Jun 30, 2025 | 87.26% |
| Mar 31, 2025 | 32.89% |
| Dec 31, 2024 | 30.72% |
| Sep 30, 2024 | 54.69% |
| Jun 30, 2024 | 38.88% |
| Mar 31, 2024 | 76.81% |
| Dec 31, 2023 | 65.43% |
| Sep 30, 2023 | 44.57% |
| Jun 30, 2023 | 38.83% |
| Mar 31, 2023 | 47.45% |